NCT04005378 Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
| NCT ID | NCT04005378 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Northwell Health |
| Condition | First Episode Psychosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2020-07-01 |
| Primary Completion | 2024-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 300 participants in total. It began in 2020-07-01 with a primary completion date of 2024-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Maintaining treatment engagement is critical for first episode psychosis patients to experience gains possible with coordinated specialty care (CSC). This study is designed to identify CSC participants still receiving care but at high risk for disengagement and to intervene to prevent/delay disengagement.
Eligibility Criteria
Inclusion Criteria: * Enrolled into a CSC program Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04005378 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 40 Years, studying First Episode Psychosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT04005378 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT04005378 currently recruiting?
Yes, NCT04005378 is actively recruiting participants. Contact the research team at pmarcy@northwell.edu for enrollment information.
Where is the NCT04005378 trial being conducted?
This trial is being conducted at Lauderdale Lakes, United States, Grand Rapids, United States, Kalamazoo, United States.
Who is sponsoring the NCT04005378 clinical trial?
NCT04005378 is sponsored by Northwell Health. The trial plans to enroll 300 participants.